Antiplatelet therapies for secondary stroke prevention: an update on clinical and cost-effectiveness.

about

Comparison of the flexible parametric survival model and Cox model in estimating Markov transition probabilities using real-world data

P2860

Q58723599-3DAA719C-BD94-408D-BB72-56A5E43ADAFD

P2860

Antiplatelet therapies for secondary stroke prevention: an update on clinical and cost-effectiveness.

Item

http://www.wikidata.org/entity/Q38566809

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Antiplatelet therapies for sec ...... inical and cost-effectiveness.

@en

type

Item

label

Antiplatelet therapies for sec ...... inical and cost-effectiveness.

@en

prefLabel

Antiplatelet therapies for sec ...... inical and cost-effectiveness.

@en

P1476

Antiplatelet therapies for sec ...... inical and cost-effectiveness.

@en

P2093

Julia M Rothlisberger

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke

Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

P304

377-384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/CER.15.22

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bruce Ovbiagele

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26274799

http://www.w3.org/2001/XMLSchema#string

P932

5549663

http://www.w3.org/2001/XMLSchema#string

Antiplatelet therapies for secondary stroke prevention: an update on clinical and cost-effectiveness.

about

P2860

P2860

Antiplatelet therapies for secondary stroke prevention: an update on clinical and cost-effectiveness.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932